Physician profile
Eric H Kim
NPI 1992068019
$24,269.53
in general payments reported to CMS, 2019-2025
24 companies · $635 in 2025
The $635 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,919 · 2021: $103 · 2022: $296 · 2023: $5,048 · 2024: $5,161 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Food and Beverage: $2,126 · Travel and Lodging: $1,619 · Consulting Fee: $1,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Food and Beverage | $2,125.56 |
| Travel and Lodging | $1,619.25 |
| Consulting Fee | $1,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,627.60 | 2019-2025 | Da Vinci Surgical System |
| E.R. Squibb & Sons, L.L.C. | $4,352.69 | 2019 | |
| Histosonics, INC. | $2,115.43 | 2024-2025 | |
| Janssen Research & Development, LLC | $946.96 | 2019 | |
| Boston Scientific Corporation | $655.04 | 2019-2024 | Spaceoar Vue System - 10ml, Lithovue |
| Covidien LP | $550.00 | 2019 | |
| Becton, Dickinson and Company | $309.71 | 2023 | Bard Urinary Drainage Bag |
| Conmed Corporation | $300.00 | 2019 | |
| Angiodynamics, INC. | $293.34 | 2023 | Nanoknife |
| Calyxo, INC. | $242.75 | 2024 | Cvac Aspiration System |
| Neotract INC. | $133.65 | 2019 | |
| Janssen Scientific Affairs, LLC | $124.96 | 2019-2025 | |
| Baxter Healthcare | $115.49 | 2024 | Perclot |
| Teleflex LLC | $98.35 | 2022-2023 | Urolift, Weck |
| Innovation Technologies INC | $94.59 | 2023 | Irrisept |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $66.49 | 2023 | |
| 180 Medical, INC. | $47.12 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $46.64 | 2025 | Orgovyx |
| Astellas Pharma US INC | $34.42 | 2023 | Xtandi |
| Abbvie INC. | $30.90 | 2022-2023 | |
| Janssen Biotech, INC. | $26.76 | 2025 | Erleada |
| Convatec INC. | $25.13 | 2022 | |
| Merck Sharp & Dohme LLC | $22.97 | 2023 | Welireg, Lynparza, Keytruda |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.